Actively Recruiting
Study of How People Make Decisions About Prostate Cancer Risk
Led by Memorial Sloan Kettering Cancer Center · Updated on 2026-04-22
150
Participants Needed
1
Research Sites
100 weeks
Total Duration
On this page
Sponsors
M
Memorial Sloan Kettering Cancer Center
Lead Sponsor
C
CureBRCA Foundation
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this study is to learn how people with BRCA1/2 mutations respond to genetic risk modifier testing. The researchers will learn more about how people make choices about their health care, including about methods to screen for prostate cancer. Researchers are also doing this study to learn about how the genetic risk modifier test affects people's thoughts and feelings.
CONDITIONS
Official Title
Study of How People Make Decisions About Prostate Cancer Risk
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients must not have prostate cancer
- Age between 45 and 70 years
- Assigned male sex at birth
- Completed genetic testing confirming a BRCA1/2 likely pathogenic or pathogenic variant
- Able to communicate in English to complete surveys
You will not qualify if you...
- Major psychiatric illness or cognitive impairment preventing participation
- Unable to comply with study procedures
- Undergoing active treatment for any malignancy
- Enrolled in NCI study 19-C-0040
- Have pathogenic variants in cancer genes other than BRCA1/2
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Memorial Sloan Kettering Cancer Center
New York, New York, United States, 10065
Actively Recruiting
Research Team
J
Jada Hamiliton, PhD, MPH
CONTACT
K
Kenneth Offit, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here